Similar articles

• The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.

  Wirtshafter D, Osborn CV. Wirtshafter D, et al. Eur J Pharmacol. 2005 Dec 28;528(1-3):88-94. doi: 10.1016/j.ejphar.2005.11.003. Epub 2005 Dec 1. Eur J Pharmacol. 2005. PMID: 16324697
• Transient dopamine synthesis modulation in prefrontal cortex: in vitro studies.

  Dumont NL, Andersen SL, Thompson AP, Teicher MH. Dumont NL, et al. Brain Res Dev Brain Res. 2004 Jun 21;150(2):163-6. doi: 10.1016/j.devbrainres.2004.02.010. Brain Res Dev Brain Res. 2004. PMID: 15158079
• Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.

  Calabresi P, Mercuri NB, Sancesario G, Bernardi G. Calabresi P, et al. Brain. 1993 Apr;116 ( Pt 2):433-52. Brain. 1993. PMID: 8096420
• Effects of neuroleptics on striatal dopamine synthesized from 14C-tyrosine.

  Nyback H, Sedvall G. Nyback H, et al. Pharmacol Ther B. 1976;2(1):49-63. doi: 10.1016/0306-039x(76)90018-0. Pharmacol Ther B. 1976. PMID: 772722 Review. No abstract available.
• Dopamine receptors: functions, subtypes and emerging concepts.

  Kaiser C, Jain T. Kaiser C, et al. Med Res Rev. 1985 Apr-Jun;5(2):145-229. doi: 10.1002/med.2610050202. Med Res Rev. 1985. PMID: 3887065 Review. No abstract available.